Abiopharma

MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b INFLO-1 Study and Enrollment of First Patient in Phase 2 INFLO-2 Trial for Nintedanib DPI in Patients with IPF

Update regarding Hadera power station project expansion and exercise of the option to extend the lease agreement on the land owned by the subsidiary (in chain) Infinia

IDEAYA Biosciences Announces Clinical Collaboration with Roche in MTAP-Deleted RAS-Mutant Pancreatic Cancer

Register of shareholders, changes and capital status – issuance of deferred debentures (Series 6)

Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing

Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation

Yuanbao Inc. to Announce First Quarter 2026 Financial Results on Wednesday, June 10, 2026

High Tide to Announce Second Fiscal Quarter 2026 Financial Results

Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing

KBR Mission Technology Solutions Awarded $8 Billion Antarctic Science and Engineering Support Contract by the U.S. National Science Foundation